Dr. Morris is a medical device C-Suite Executive and a public/private company independent board member. He most recently led Neuspera Medical, Inc. as Chairman and CEO. Prior to joining Neuspera, he was the Senior Vice President of Research & Development and Emerging Therapies at Cyberonics, Inc. (now LivaNova, PLC). Previously, he held several positions of increasing responsibility at Guidant Corporation and its successor, Boston Scientific Corporation, including Principal Research Scientist, Director, Research & Development and Director, Marketing. Prior to joining Guidant, he worked as a Research Assistant in the Medical Computing Laboratory at the University of Michigan.
Dr. Morris is a member of the Board of Directors of Myomo, Inc. (NYSE: MYO) and of Nordson Corporation (NASDAQ: NDSN). He serves on the Board of Trustees for Northwestern University, where he chairs the Northwestern Medicine Committee, and is a Fellow in the American Institute for Medical and Biological Engineering. He holds a Master of Business Administration from Northwestern University's Kellogg School of Management, a Master's and Ph.D. in Electrical Engineering from the University of Michigan and a Bachelor of Science in Electrical Engineering from Northwestern University.
Dr. Morris brings to the Board his leadership experience in the medical industry, his expertise in developing and successfully launching new medical device products, and his deep knowledge of the medical field, as well as extensive experience in global business, operations and manufacturing, strategy and innovation, payer and medical reimbursement, risk and crisis management, regulatory and compliance matters, cybersecurity and information systems, and experience with institutional investors.